Abacus Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Sell
488
-37
-7% -$17.8K 0.03% 278
2026
Q1
$258K Sell
525
-61
-10% -$33.1K 0.02% 404
2025
Q4
$340K Buy
+586
New +$331K 0.03% 311
2025
Q2
Sell
-408
Closed -$203K 117
2025
Q1
$203K Sell
408
-9
-2% -$4.87K 0.03% 85
2024
Q4
$217K Sell
417
-45
-10% -$24.7K 0.03% 80
2024
Q3
$286K Buy
+462
New +$273K 0.04% 70

Other funds holding TMO

Abacus Wealth Partners's TMO Position: Q2 2026 in Review

Abacus Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 7% in Q2 2026, selling an estimated $17.8K and leaving 488 shares worth $245K. The position accounts for 0.03% of the portfolio, ranked #278.

Abacus Wealth Partners first reported a position in TMO in Q3 2024 and has held it in 6 quarters since. The position peaked at $340K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Abacus Wealth Partners held 488 shares of Thermo Fisher Scientific worth $245K as of Q2 2026.
  • Abacus Wealth Partners sold 37 Thermo Fisher Scientific shares in Q2 2026, an estimated $17.8K.
  • Thermo Fisher Scientific made up 0.03% of Abacus Wealth Partners's portfolio in Q2 2026, its #278 holding.
  • Abacus Wealth Partners first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 6 quarters since.
  • Abacus Wealth Partners's Thermo Fisher Scientific position peaked at $340K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Abacus Wealth Partners's 13F filing for Q2 2026, filed 22 Jul 2026.